Digestive

NEW YORK — New findings that support the use of probiotics in treating a variety of disorders are helping to create interest in the category, according to Kline’s “Digestive Health, Immunity, and Probiotics: U.S. Market Analysis and Opportunities” published in late August.

NEW YORK — Last month, the last of the branded proton-pump inhibitors was opened to store-brand competition as Perrigo brought a Nexium 24HR equivalent to market. Speaking with analysts, Perrigo president and CEO John Hendrickson expected private label to grab at least a 25% share of the $300 million in Nexium 24HR sales. “It’s been three years without having a store-brand equivalent to Nexium,” Hendrickson said. “We have the other PPIs in our portfolio, but not that.”

NEW YORK — As many as 16% of those Americans who take supplements actively take a fiber supplement, according to the Council for Responsible Nutrition 2016 Annual Survey on Dietary Supplements. And usage skews younger — 21% of adults between the ages of 18 and 34 years old who supplement take fiber, compared to 9% of adults over the age of 55 years who take a supplement.

NEW YORK — Pfizer on Tuesday might be putting its $3.4 billion consumer healthcare business on the sales block, noting that all scenarios would be considered during a strategic review of its options, which include a full or partial separation of the business from Pfizer through a spin-off, sale or other transaction.

Of course, Pfizer may ultimately determine to retain the business, the company added.

DUBLIN — Perrigo has begun shipping its over-the-counter store-brand Nexium 24HR capsules, the company announced Tuesday, noting that it was first-to-market with the heartburn treatment equivalent.

WAUKESHA, Wis.— Hamacher Resource Group on Tuesday announced the completion of its semiannual update to its taxonomy system for health, beauty and wellness, home health care and general merchandise products with notable adjustments to reflect industry changes.

The September 2017 Fine Lines updates include the move of motion sickness and vertigo products from Pain Relief to a new subcategory “nausea and motion sickness” in Digestive Health.

HORSHAM, Pa. — Reliefband, a wearable, drug-free solution for nausea, on Tuesday announced a distribution partnership with AmerisourceBergen.

“Today’s healthcare environment necessitates a partner that has the size, reach and scale to deliver a product to patients at the right time,” stated Nick Spring, CEO of Reliefband Technologies. “This new relationship will significantly strengthen and grow our business, increasing our ability to provide innovative solutions to our customers.”

SAN DIEGO, Calif.  — “We all love predictability and feel stress during moments of change and disruption. But the future is about expanding in our intangible leadership skills so we can better manage the changing environment. There has been too much change in too short of time. Tomorrow is all about how you think, not just what you know. We must all expand our capacity. Amazon has disrupted everyone’s journey, and we must change along with it.”